Skip to content

A comparative assessment of Salvia officinalis gel and Triamcinolon asetonolyd gel regarding the duration and symptoms of oral lichenoid reaction

A comparative assessment of Triamcinolon asetonlyd gel and Salvizan gel(containing extract of Salvia officinalis) regarding the duration and symptoms of lichenoid reaction.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015061422706N1
Enrollment
60
Registered
2015-08-12
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lichenoid reaction. Lichen simplex chronicus

Interventions

Intervention 1: standard drug: triamcinolone gel 0.1 % The drug was administered three times a day to the 1 cm on the fervent mucosa. The pain level in patients According Question and The extent o
Treatment - Drugs
standard drug: triamcinolone gel 0.1 % The drug was administered three times a day to the 1 cm on the fervent mucosa. The pain level in patients According Question and The extent of lesions accor
intervention drug: salvizan gel contains 28% hydroalcoholic extract The drug was administered three times a day to the 1 cm on the fervent mucosa. The pain level in patients According Questio

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: maximum age of 60 years; minimum age of 20 years; non-pregnant; non-breastfeeding women; ability to remain during the study period. exclusion criteria:The patients with allergy to plant products; drug abuse; those who were reluctant to cooperate.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Extent of lesions. Timepoint: baseline, seventh day, the fourteenth day. Method of measurement: 0 to 5according to the parameters mentioned by Buajeeb.;Pain. Timepoint: baseline, seventh day, the fourteenth day. Method of measurement: according to the Visual Analog Scale (VAS) from 0 to 10.;Drug type. Timepoint: baseline, seventh day, the fourteenth day. Method of measurement: method.

Secondary

MeasureTime frame
Burning and sensivity from drug. Timepoint: baseline, seventh day, the fourteenth day. Method of measurement: ask the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbasi Fatemeh

Dental College of Isfahan University of Medical Sciences

ghalayani@dnt.mui.ac.irf.abac@yahoo.comresearch@dnt.mui.ac.ir ghalayani@dnt.mui.ac.irf.ab+98 31 3792 5512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026